Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Guido Gini, MD, Mariagrazia Michieli, Bernardino Allione, Luisa Verga, MD, Caterina Bocci, Michele Spina, MD, Stefania Tamiazzo, Alessandra Bandera, Flavia Salvi, MD, Annalisa Peli, MD, Moira Micheletti, Camillo Almici, MD, Pierino Ferremi, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 2528.

https://doi.org/10.1182/blood.V124.21.2528.2528

Published: 2014

Journal Articles

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

Blood (2013) 122 (19): 3251–3262.

https://doi.org/10.1182/blood-2013-04-498964

Published: 2013

Includes: Supplemental data

Journal Articles

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

Stefan K Barta, MD, MS, MRCP, Xiaonan Xue, Ph.D., Dan Wang, MS, Jeannette Y Lee, Ph.D., Lawrence D. Kaplan, MD, Josep-Maria Ribera, MD, PhD, Albert Oriol, Olga Garcia, Mireia Morgades, Michele Spina, MD, Umberto Tirelli, MD, Francois Boue, MD, PhD, Wyndham H. Wilson, MD, PhD, Christoph Wyen, MD, Kieron Dunleavy, MD, Joseph A Sparano, MD

Blood (2012) 120 (21): 1564.

https://doi.org/10.1182/blood.V120.21.1564.1564

Published: 2012

Journal Articles

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Blood (2012) 120 (21): 3682.

https://doi.org/10.1182/blood.V120.21.3682.3682

Published: 2012

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Alessandro Re, MD, Mariagrazia Michieli, Bernardino Allione, MD, Salvatore Casari, MD, Chiara Cattaneo, MD, Michele Spina, Andrea Gori, Elisa Garlassi, Luisa Verga, MD, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Alessandro Levis, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2012) 120 (21): 3124.

https://doi.org/10.1182/blood.V120.21.3124.3124

Published: 2012

Journal Articles

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

Marta Bruno Ventre, MD, Giovanni Donadoni, MD, Alessandro Re, MD, Michele Spina, MD, Chiara Cattaneo, Luca Fumagalli, MD, Silvia Mappa, MD, Silvia Govi, MD, Giuseppe Rossi, MD, Umberto Tirelli, MD, Andrés JM Ferreri, MD

Blood (2011) 118 (21): 2692.

https://doi.org/10.1182/blood.V118.21.2692.2692

Published: 2011

Journal Articles

HAART Does Not Improve the Outcome of HIV-Related Multicentric Castleman Disease: Results of a Multicentric Retrospective Study

Chiara Cattaneo, Emanuela Vaccher, Alessandro Re, MD, Salvatore Casari, Erika Borlenghi, Michele Spina, MD, Umberto Tirelli, MD, Giuseppe Rossi

Blood (2011) 118 (21): 4918.

https://doi.org/10.1182/blood.V118.21.4918.4918

Published: 2011

Journal Articles

Phase II Study of Intrathecal Long Acting Liposomal Cytarabine (Depocyte ® ) In the Prophylaxis of Lymphomatous Meningitis In HIV-Related Non-Hodgkin's Lymphoma

Michele Spina, MD, Ferdinando Martellotta, Massimiliano Berretta, Ernesto Zanet, Arben Lleshi, Vincenzo Canzonieri, Pietro Bulian, Michele Bibas, MD, Andrea Antinori, Umberto Tirelli

Blood (2010) 116 (21): 1750.

https://doi.org/10.1182/blood.V116.21.1750.1750

Published: 2010

Journal Articles

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (CDE) In Combination with HAART In HIV-Related Non-Hodgkin's Lymphomas (NHL)

Michele Spina, MD, Ulrich Jaeger, MD, Joseph A Sparano, Renato Talamini, Giuseppe Rossi, MD, Emanuela Vaccher, Umberto Tirelli

Blood (2010) 116 (21): 5072.

https://doi.org/10.1182/blood.V116.21.5072.5072

Published: 2010

Journal Articles

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

Michele Spina, MD, Jean Gabarre, MD, Salvatrice Mancuso, Alessandro Re, Clara Schiantarelli, Renato Talamini, Emanuela Vaccher, Umberto Tirelli

Blood (2010) 116 (21): 4827.

https://doi.org/10.1182/blood.V116.21.4827.4827

Published: 2010

Journal Articles

Hodgkin's Disease and HIV Infection (HD-HIV): Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT)

Michele Spina, MD, Josep-Maria Ribera, MD, PhD, Jean Gabarre, MD, Christoph Wyen, Silvia Montoto, MD, Ulrich Jaeger, MD, Renato Talamini, Alessandro Re, Pilar Miralles, Umberto Tirelli

Blood (2010) 116 (21): 3883.

https://doi.org/10.1182/blood.V116.21.3883.3883

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Mobilization In Hiv Positive Patients with Lymphoma Candidates to Autologous Transplantation: Predictive Factors Analysis for Failure or Suboptimal Stem Cell Collection

Alessandro Re, Pascual Balsalobre, Mariagrazia Michieli, Jose M. Ribera, MD, PhD, Bernardino Allione, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Chiara Cattaneo, Salvatore Casari, Michele Spina, MD, Cristina Skert, Jose L. Diez-Martin, MD, PhD, Umberto Tirelli, Giuseppe Rossi, MD

Blood (2010) 116 (21): 2250.

https://doi.org/10.1182/blood.V116.21.2250.2250

Published: 2010

Journal Articles

Comprehensive Geriatric Assessment-Adapted Chemotherapy in Elderly Patients (>70 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL): Final Results and Long Term Follow-up.

Umberto Tirelli, MD, Lucia Fratino, Monica Balzarotti, Lilj Uziel, Annalisa Giacalone, Andres Ferreri, Armando Santoro, Michele Spina, MD

Blood (2009) 114 (22): 2684.

https://doi.org/10.1182/blood.V114.22.2684.2684

Published: 2009

Journal Articles

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).

Rita Mazza, MD, Stefano Luminari, Massimo Magagnoli, MD, Michele Spina, MD, Teodoro Chisesi, MD, Antonio Pinto, MD, Massimo Federico, MD, Antonella Anastasia, MD, Arturo Chiti, MD, Mariagrazia Michieli, MD, Francesco Angrilli, MD, Luca Castagna, Giampaolo Marcacci, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro, Monica Balzarotti

Blood (2009) 114 (22): 3707.

https://doi.org/10.1182/blood.V114.22.3707.3707

Published: 2009

Journal Articles

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV).

Antonella Anastasia, MD, Monica Balzarotti, Massimo Magagnoli, MD, Michele Spina, MD, Rita Mazza, MD, L. Castagna, Andrea Nozza, Stefania Bramanti, md, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro

Blood (2009) 114 (22): 1213.

https://doi.org/10.1182/blood.V114.22.1213.1213

Published: 2009

Journal Articles

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

Alessandro Re, Mariagrazia Michieli, Salvatore Casari, Bernardino Allione, Chiara Cattaneo, Maurizio Rupolo, Michele Spina, Rosa Manuele, Emanuela Vaccher, Mario Mazzucato, Luciano Abbruzzese, Pierino Ferremi, Giampiero Carosi, Umberto Tirelli, Giuseppe Rossi

Blood (2009) 114 (7): 1306–1313.

https://doi.org/10.1182/blood-2009-02-202762

Published: 2009

Journal Articles

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV): Final Results of the Italian Cooperative Group on AIDS and Tumors (GICAT) Study.

Michele Spina, MD, Andrea Antinori, Valentina Neri, Giuseppe Rossi, Alessandro Re, Bernardino Allione, Emanuela Chimienti, Renato Talamini, Umberto Tirelli

Blood (2008) 112 (11): 1466.

https://doi.org/10.1182/blood.V112.11.1466.1466

Published: 2008

Journal Articles

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (cde) in Combination with HAART in HIVRelated Non-Hodgkin’s Lymphomas (NHL).

Michele Spina, MD, Cecilia Simonelli, Emanuela Vaccher, Ulrich Jaeger, MD, Joseph Sparano, MD, Renato Talamini, Umberto Tirelli

Blood (2008) 112 (11): 1467.

https://doi.org/10.1182/blood.V112.11.1467.1467

Published: 2008

Journal Articles

Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity

Rita Mazza, MD, Monica Demarco, MD, Michele Spina, MD, Massimo Magagnoli, MD, Luca Castagna, MD, Licia Siracusano, MD, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro, MD, Monica Balzarotti, MD

Blood (2008) 112 (11): 3593.

https://doi.org/10.1182/blood.V112.11.3593.3593

Published: 2008

Journal Articles

Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma

Jessica Dal Col, Paola Zancai, Liliana Terrin, Massimo Guidoboni, Maurilio Ponzoni, Alessandro Pavan, Michele Spina, Stefano Bergamin, Silvana Rizzo, Umberto Tirelli, Anita De Rossi, Claudio Doglioni, Riccardo Dolcetti

Blood (2008) 111 (10): 5142–5151.

https://doi.org/10.1182/blood-2007-07-103481

Published: 2008

NARROW

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

ARL-IPI - A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab Era

A Pooled Analysis of 1,546 Patients with HIV-Associated Lymphoma: Assessment of Lymphoma-, HIV-, and Treatment-Specific Factors On Clinical Outcomes

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Safety and Activity of Intensive Short-Term Chemoimmunotherapy in HIV-Positive (HIV+) Patients (pts) with Burkitt Lymphoma (BL)

HAART Does Not Improve the Outcome of HIV-Related Multicentric Castleman Disease: Results of a Multicentric Retrospective Study

Phase II Study of Intrathecal Long Acting Liposomal Cytarabine (Depocyte ® ) In the Prophylaxis of Lymphomatous Meningitis In HIV-Related Non-Hodgkin's Lymphoma

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (CDE) In Combination with HAART In HIV-Related Non-Hodgkin's Lymphomas (NHL)

Long Term Results of Stanford V Regimen and Highly Active Antiretroviral Therapy (HAART) In 59 Patients (pts) with HD and HIV Infection (HD-HIV)

Hodgkin's Disease and HIV Infection (HD-HIV): Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT)

Peripheral Blood Stem Cell Mobilization In Hiv Positive Patients with Lymphoma Candidates to Autologous Transplantation: Predictive Factors Analysis for Failure or Suboptimal Stem Cell Collection

Comprehensive Geriatric Assessment-Adapted Chemotherapy in Elderly Patients (>70 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL): Final Results and Long Term Follow-up.

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV).

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV): Final Results of the Italian Cooperative Group on AIDS and Tumors (GICAT) Study.

Long-Term Follow-up of Rituximab and Infusional Cyclophosphamide, Doxorubicin, and Etoposide (cde) in Combination with HAART in HIVRelated Non-Hodgkin’s Lymphomas (NHL).

Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity

Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only